Filter
768
Text search:
medicine
prices
Featured
65
233
Language
Document type
407
206
72
35
24
8
7
6
2
1
Countries / Regions
33
31
26
19
18
18
15
15
14
14
14
12
12
12
11
11
10
9
9
9
8
8
8
8
8
7
7
6
6
6
5
5
5
5
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
319
70
48
22
18
14
2
Toolboxes
67
56
56
46
43
36
28
28
18
15
15
13
11
11
10
8
7
7
2
1
1
Towards a Healthier Botswana
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Lessons from the STEP-TB Project.
Accessed November 2017.
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who release
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Modelling the health impacts of disruptions to essential health services during COVID-19 Module 1
Several epidemiological models have been created to assess the potential impact of disruptions to essential health services caused by COVID-19 on morbidity and mortality from conditions other than COVI
...
